We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Eli Lilly Scores In Zyprexa Patent Feud

Law360 (January 2, 2007, 12:00 AM EST) -- In a blow to a group of generic drug makers, a U.S. appeals court has affirmed a lower court’s decision that upheld Eli Lilly & Co.’s patent on blockbuster schizophrenia drug...
To view the full article, register now.